What is the Cryosite (ASX: CTE) share price?
The CTE share price is $1.06, up 0.00% for the day, based on the latest available ASX market data.
What is Cryosite's market capitalisation?
Cryosite has a market capitalisation of $51.7M, making it the 1003rd-largest security listed on the ASX.
Does Cryosite pay a dividend?
CTE does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.
What is CTE's P/E ratio?
Cryosite trades on a trailing price-to-earnings (P/E) ratio of 10.72, based on its current share price and most recent reported earnings.
Is Cryosite profitable?
Yes. In its most recent reported period (ending 31 Dec 2025), CTE reported revenue of $8.3M and a net profit of $1.1M.
How many CTE shares are on issue?
Cryosite has approximately 48,809,563 shares on issue, based on its market capitalisation of $51.7M and current share price.
What sector is Cryosite in?
Cryosite is classified in the Healthcare sector, within the Medical - Diagnostics & Research industry on the ASX.
When did Cryosite list on the ASX?
Cryosite listed on the Australian Securities Exchange on 9 May 2002.
